中国媒介生物学及控制杂志

• 分题报告 • 上一篇    下一篇

江西省肾综合征出血热灭活疫苗(Ⅰ型)的安全性和免疫效果

胡美娇1; 张平均1; 朱丽萍1; 廖忠1; 李育强1; 丁晟1; 周江东2; 张以耕2; 陈运鸿2; 涂卫国2   

  1. 1.江西省卫生防疫站 南昌 330046;2.奉新县卫生防疫站
  • 出版日期:1996-08-20 发布日期:1996-08-20

Observation on the Safety and Efficacy of Inactivated Vaccine(Type Ⅱ) against HFRS

Hu Mei-jiao;Zhang Ping-jun;Zhu Li-ping et al   

  1. Jiangxi Provincial Health and Anti-Epidemic Station,Nanchang 330046
  • Online:1996-08-20 Published:1996-08-20

摘要: 为探讨肾综合征出血热地鼠肾细胞Ⅱ型灭活疫苗在混合型疫区接种的安全性及免疫效果,于1994年首次在本病高发的奉新县赤岸乡,按0、28、42天免疫程序,对10个村6140名16~60岁高发人群进行全程免疫,1995年用新制的同型苗加强接种1针。结果:①全程接种后2周、12个月和加强后2周,血清中和抗体1:5阳转率分别为88.24%、14.81%和100%,几何平均滴度(GMT)分别是13.58、5.83和14.34。IFAT阳转率分别为76.32%、85.19%和100%,GMT分别为14.99、17.59和80.00。RPHI阳转率分别为65.79%、66.67%和96.30%,GMT分别是12.01、12.60和68.58。表明该苗能有效地诱导抗体反应。②接种组没有病例,对照组发病10例,发病率117.08/10万,保护率100%,疫苗近期防病效果好。③疫苗接种后反应轻微,个别人出现异常反应,安全性好。④本次研究首次证实Ⅱ型苗在混合型疫区的防病效果。

关键词: HFRS疫苗, 地鼠肾细胞, 免疫效果

Abstract: In order to study the safety and efficacy of inactivated vaccine(type Ⅱ) prepared from golden hamster kidne cell(GHKC) against HFRS, 6140 healthy people, whose age was 16 to 60 years old, was injected three times on 0,28 day and 42 day, at 10 villages of Chian township, Fengxin county in 1994, which was made a supplementary injection in 1995.The level of antibody in serum, 2 weeks,12 months and 12.5 months after the first injection was observed. The neutralization antiboby(1:5) positive rates were 88.24%,14.81% and 100%.The geometric mean titer (GMT)of neutralization antiboby were 13.58,5.83 and 14.34 Seroconversion rates of IFAT antiboby(three times) were 76.37%,85.19% and 100% respectively. The GMT of them were 14.99,17.59 and 80.00. Seroconversion rates of RPHI antibody (three times) were 65.79% ,66.67%,and 96.30% respectively. The GMT of them were 12.01,12.60 and 68.58. These data demonstrated that the vaccine could effectively induce specific antibody responses.The tested group has no case developed in this sub-population. There were 10 cases of HFRS in the control group,making the incidence 117.08/105, and the protection rate were 100 %.The reactions of injection were slight and local reactions were only found in few people.It showed that the vaccine was safe. For the first time it revealed that the vaccine type Ⅱ had satisfactory immune effect in the epidemic area of mixed type.